184 related articles for article (PubMed ID: 11958903)
21. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy.
Diavolitsis V; Rademaker A; Lurain J; Hoekstra A; Strauss J; Small W
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):415-9. PubMed ID: 22365625
[TBL] [Abstract][Full Text] [Related]
23. Is endometrial carcinoma intrinsically more aggressive in elderly patients?
Alektiar KM; Venkatraman E; Abu-Rustum N; Barakat RR
Cancer; 2003 Dec; 98(11):2368-77. PubMed ID: 14635071
[TBL] [Abstract][Full Text] [Related]
24. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
25. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
[TBL] [Abstract][Full Text] [Related]
26. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
27. Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway.
Ørbo A; Rydningen M; Straume B; Lysne S
Int J Gynecol Cancer; 2002; 12(1):49-56. PubMed ID: 11913358
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
29. Postoperative radiotherapy in intermediate and high-risk Stage I endometrial cancer: analysis of prognostic factors and survival.
Bolukbasi Y; Demirci S; Ozsaran Z; Yalman D; Hanhan M; Ozsaran A; Dikmen Y; Aras A
Eur J Gynaecol Oncol; 2008; 29(5):505-10. PubMed ID: 19051823
[TBL] [Abstract][Full Text] [Related]
30. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
[TBL] [Abstract][Full Text] [Related]
31. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
32. An analysis of two versus three grades for endometrial carcinoma.
Taylor RR; Zeller J; Lieberman RW; O'Connor DM
Gynecol Oncol; 1999 Jul; 74(1):3-6. PubMed ID: 10385544
[TBL] [Abstract][Full Text] [Related]
33. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort.
Boennelycke M; Peters EEM; Léon-Castillo A; Smit VTHBM; Bosse T; Christensen IJ; Ørtoft G; Høgdall C; Høgdall E
Virchows Arch; 2021 Sep; 479(3):507-514. PubMed ID: 34117532
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.
Chen KS; Berhane H; Gill BS; Olawaiye A; Sukumvanich P; Kelley JL; Boisen MM; Courtney-Brooks M; Comerci JT; Edwards R; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):315-319. PubMed ID: 28866431
[TBL] [Abstract][Full Text] [Related]
36. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
38. Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.
Scholten AN; van Putten WL; Beerman H; Smit VT; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van Lent M; Creutzberg CL;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):834-8. PubMed ID: 15927414
[TBL] [Abstract][Full Text] [Related]
39. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
